A detailed history of Geneos Wealth Management Inc. transactions in Geron Corp stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 1,500 shares of GERN stock, worth $6,105. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,500
Previous 1,500 -0.0%
Holding current value
$6,105
Previous $6,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 11, 2023

BUY
$2.11 - $3.28 $1,055 - $1,640
500 Added 50.0%
1,500 $3,000
Q1 2023

Apr 25, 2023

BUY
$2.14 - $3.4 $2,140 - $3,400
1,000 New
1,000 $2,000
Q2 2021

Jul 08, 2021

SELL
$1.25 - $1.83 $125 - $183
-100 Reduced 9.09%
1,000 $1,000
Q1 2021

Jun 17, 2021

BUY
$1.52 - $2.1 $152 - $210
100 Added 10.0%
1,100 $1,000
Q1 2020

Sep 07, 2021

BUY
$0.89 - $1.49 $890 - $1,490
1,000 New
1,000 $1,000
Q4 2017

Sep 07, 2021

SELL
$1.8 - $2.32 $1,778 - $2,292
-988 Closed
0 $0
Q1 2016

Sep 07, 2021

BUY
N/A
988
988 $2,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.54B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.